News Focus
News Focus
Post# of 318399
Next 10
Followers 367
Posts 114722
Boards Moderated 5
Alias Born 12/28/2000

Re: None

Monday, 04/27/2026 8:48:25 AM

Monday, April 27, 2026 8:48:25 AM

Post# of 318399
CMPX down over 70% - their drug candidate, tovecimig, failed to meet the overall survival secondary endpoint in the COMPANION-002 study for bile duct cancer

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today